Skip to main content
OpenTrials

Clinical trial condition

Bladder Cancer

Explore clinical trials studying Bladder Cancer. Study availability and eligibility vary by location and protocol.

771 public trials 174 recruiting studies
Refine in advanced search Browse all conditions

Bladder Cancer trial results

Completed

Combination Chemotherapy in Treating Patients With Bladder Cancer

NCT00003701

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
  • Indiana University Hospitals Indianapolis, Indiana, United States
  • Hunterdon Regional Cancer Center Flemington, New Jersey, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View all 13 locations
View Trial Details
Completed

Mind-Body Health in Uro-Oncology: Research Study

NCT03852030

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
View Trial Details
Completed

CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)

NCT02043665

Conditions
Bladder Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • John Wayne Cancer Institute Santa Monica, California, United States
  • University of Miami Coral Gables, Florida, United States
  • Advocate Health Niles, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
View all 18 locations
View Trial Details
Completed

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

NCT02371447

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • Universitätsklinikum der Ruhr-Universität Bochum Herne, Germany
  • Universitätsklinikum Jena Jena, Germany
  • Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz, Germany
View all 16 locations
View Trial Details
Completed

Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO)

NCT03472274

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ICO Badalona Badalona, Spain
  • Hospital Clinic Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • ICO L'Hospitalet L'Hospitalet de Llobregat, Spain
View Trial Details

Related conditions